INTRODUCTION
============

Approximately 50% of trauma patients who present to the emergency department (ED) die within 24 hours of admission \[[@b1-acc-2019-00640],[@b2-acc-2019-00640]\]. Exsanguination is one of the major causes of death after trauma. Exsanguination most commonly occurs after central nervous system injury, which accounts for approximately 30% to 40% of all trauma-related deaths \[[@b3-acc-2019-00640]\]. It is critical to identify patients who may experience sudden massive bleeding, and provide intensive care to them in order to improve their prognosis. This intensive care may include massive transfusion (MT). Many prior studies have shown that early and proper MT can improve the prognosis of trauma patients \[[@b4-acc-2019-00640]-[@b6-acc-2019-00640]\].

Measurement of the initial lactate level may help in predicting the prognosis of critical illnesses, such as sepsis \[[@b7-acc-2019-00640],[@b8-acc-2019-00640]\] or cardiovascular disease \[[@b9-acc-2019-00640]\]. Prior studies have suggested that the initial lactate level is related to prognosis after trauma \[[@b10-acc-2019-00640],[@b11-acc-2019-00640]\]. In previous studies, the initial lactate levels could predict mortality in trauma patients \[[@b10-acc-2019-00640]\]. One prior study showed that the lactate level in trauma patients was associated with the need for blood transfusion \[[@b11-acc-2019-00640]\]. However, few studies have evaluated the relationship between the initial lactate level and MT in severe trauma.

Therefore, the purpose of this study was to analyze the prognostic impact of the initial lactate level for MT in patients with severe trauma. The clinical course of trauma patients may differ depending on the area of injury. For instance, systemic reactions may differ between patients with head injury and those with hemorrhagic shock \[[@b12-acc-2019-00640]\]. Therefore, we divided patients into traumatic brain injury (TBI) and non-TBI subgroups.

MATERIALS AND METHODS
=====================

Study Design and Population
---------------------------

We conducted a retrospective, observational study involving patients who were admitted to the Chonnam National University Hospital, Gwangju, South Korea, with severe trauma between January 2016 and December 2017. Severe trauma was defined by an Injury Severity Score (ISS) \>15 \[[@b13-acc-2019-00640]\]. The exclusion criteria were as follows: age \<18 years; lack of a lactate level result from the ED visit; specific mechanisms of trauma including drowning, hanging, or burns; traumatic cardiac arrest before the ED visit; and missing data. The study design was approved by the Institutional Review Board of Chonnam National University Hospital (IRB No. CNUH-2018-066).

Study Protocol and Data Collection
----------------------------------

The following variables were collected from each patient: age, sex, past medical history, mechanism of trauma (such as blunt or penetrating), systolic blood pressure (SBP, mm Hg), respiratory rate, pulse rate, and Glasgow Coma Scale (GCS) on arrival, laboratory data on admission (including the white blood cell count, hemoglobin, platelet count, aspartate transaminase, alanine aminotransferase, activated partial thromboplastin time \[aPTT\], international normalized ratio of prothrombin time \[PT-INR\], and lactate level), the amount of transfused packed red blood cells (PRCs) within the first 24 hours of trauma, the need for emergent surgery and emergency interventions, length of stay in the hospital and intensive care unit, in-hospital mortality, and 30-day mortality. The Abbreviated Injury Scale (AIS) score and ISS were measured from the ED visit. The revised trauma score (RTS) was measured using the GCS and vital signs. The head AIS scores ≥3 were defined as the TBI \[[@b14-acc-2019-00640]\]. The primary outcome was the MT, considered as a transfusion of ≥10 units of PRC within the first 24 hours of arrival.

Statistical Analysis
--------------------

We described the continuous variables as median values with interquartile ranges, and categorical variables as frequencies and percentages. We analyzed the continuous variables using the Mann-Whitney U-test, as all of the continuous variables showed a non-normal distribution. We analyzed the categorical variables using Fisher's exact tests. Receiver operating characteristic (ROC) analysis was conducted to evaluate the prognostic performance of the RTS, ISS, hemoglobin, SBP, and lactate levels for MT. The method proposed by DeLong et al. \[[@b15-acc-2019-00640]\] was used to compare each dependent ROC curve. In order to examine the relationship between the MT and lactate levels, multivariate logistic regression analyses with backward elimination were performed. Next, subgroup analysis was performed on the TBI and non-TBI groups. The results of each model were described as odds ratio (OR) and 95% confidence interval (CI). A two-tailed significance level of 0.05 was considered statistically significant.

RESULTS
=======

Patient Selection and Baseline Characteristics
----------------------------------------------

We identified 971 patients with severe trauma during the study period. After applying the exclusion criteria, 553 patients were selected ([Figure 1](#f1-acc-2019-00640){ref-type="fig"}). The patients' baseline and clinical characteristics are shown in [Table 1](#t1-acc-2019-00640){ref-type="table"}. The median age was 59 years (interquartile range \[IQR\], 45 to 72 years). There were 411 male patients (74.3%). There were 244 and 309 patients in the TBI and non-TBI subgroups, respectively. MT was performed in 62 patients (11.2%), of which 25 (10.2%) and 37 (12.0%) were in the TBI and non-TBI groups, respectively. The in-hospital mortality was 14.8% (n=80). Penetrating injuries were more common in the MT group than they were in the no-MT group. Patients in the MT group had lower values of RTS, hemoglobin levels, and platelet counts, and higher values of ISS, aPTT, and PT-INR than did those in the no-MT group. The median lactate levels were higher in the MT group than they were in the no-MT group (5.5 \[IQR, 3.8--9.0\] vs. 2.7 \[IQR, 1.6--4.3\] mmol/L; P\<0.001). Among the TBI patients, there were no statistically significant differences between the MT and no-MT groups with regard to the mechanism of trauma or in the platelet counts ([Table 2](#t2-acc-2019-00640){ref-type="table"}).

Prognostic Performance of the Lactate Level for MT
--------------------------------------------------

The areas under the curve (AUCs) for ISS, RTS, hemoglobin, SBP, and lactate levels were 0.651 (95% CI, 0.609 to 0.690), 0.717 (95% CI, 0.677 to 0.754), 0.726 (95% CI, 0.687 to 0.763), 0.768 (95% CI, 0.730 to 0.802), and 0.779 (95% CI, 0.742 to 0.813), respectively ([Table 3](#t3-acc-2019-00640){ref-type="table"}, [Figure 2](#f2-acc-2019-00640){ref-type="fig"}A). The AUC of the lactate level was significantly different from that of ISS (P=0.006). However, the AUC of the lactate level was not significantly different from that of RTS (P=0.054), SBP (P=0.726), or the hemoglobin level (P=0.154). In TBI and non-TBI patients, the AUCs of the lactate level were 0.690 (95% CI, 0.627 to 0.747) and 0.842 (95% CI, 0.796 to 0.881), respectively ([Table 3](#t3-acc-2019-00640){ref-type="table"}). In the TBI patients, the AUC of the lactate level was significantly different from that of SBP (P=0.009) and was not different from that ISS (P=0.600), RTS (P=0.466), and the hemoglobin level (P=0.654) ([Figure 2](#f2-acc-2019-00640){ref-type="fig"}B). In the non-TBI patients, the AUC of the lactate level was significantly different from that of ISS (P=0.003), RTS (P=0.008), SBP (P=0.016) and the hemoglobin level (P=0.021) ([Figure 2](#f2-acc-2019-00640){ref-type="fig"}C). [Table 4](#t4-acc-2019-00640){ref-type="table"} displays the cutoff score, sensitivity, specificity, positive predictive value, and negative predictive value of the lactate levels in all patients (including TBI and non-TBI patients).

Relationship between Lactate Level and MT in Multivariate Analysis
------------------------------------------------------------------

[Table 5](#t5-acc-2019-00640){ref-type="table"} shows the association between the variables and MT. After adjusting for confounders, the mechanism of trauma (OR, 0.178; 95% CI, 0.041 to 0.768), SBP (OR, 0.979; 95% CI, 0.968 to 0.990), and hemoglobin (OR, 0.834; 95% CI, 0.740 to 0.940) were associated with MT. The lactate level was also independently associated with MT (OR, 1.179; 95% CI, 1.070 to 1.299). The lactate level was independently associated with MT (OR, 1.469; 95% CI, 1.262 to 1.710) in non-TBI patients, but not in TBI patients (OR, 1.002; 95% CI, 0.843 to 1.190) ([Table 5](#t5-acc-2019-00640){ref-type="table"}).

DISCUSSION
==========

In this study, the lactate level had fair discriminatory power in predicting MT. In non-TBI patients, the lactate level showed good prognostic performance for MT, and was a significant predictor of MT. In TBI patients, the lactate level showed poor prognostic performance for MT and was not associated with MT.

In trauma patients, hemorrhage leads to a decrease in the circulating volume and rapidly depletes the hemoglobin level. Therefore, oxygen supply to the tissue becomes inadequate and anaerobic metabolism increases. Anaerobic metabolism leads to lactate accumulation. Many prior studies have described a relationship between hemorrhage and lactate levels in trauma patients \[[@b11-acc-2019-00640],[@b16-acc-2019-00640],[@b17-acc-2019-00640]\]. Johnson et al. \[[@b11-acc-2019-00640]\] showed that the AUC of lactate for predicting hemorrhage \>250 ml was 0.824 in trauma patients. In another study, the lactate level was a good predictor of the need for transfusion of ≥6 units of PRC \[[@b16-acc-2019-00640]\]. In this study, lactate levels of 5.0--7.5 mmol/L and \>7.5 mmol/L were associated with the need for ≥6 units of PRC \[[@b16-acc-2019-00640]\]. In hemodynamically stable trauma patients, the lactate levels of patients who received MT were higher than were those of patients who did not receive MT (5.6 vs. 2.6 mmol/L); this finding was consistent with that of the present study \[[@b17-acc-2019-00640]\]. Despite hemodynamic stability at the time of hospital admission, the ISS score of the MT group in this study was very high (29 points) \[[@b17-acc-2019-00640]\]. Penetrating injuries in the MT group were more common than they were in the no-MT group. This finding was similar to that in the present study.

Many studies have reported that patients with TBI have hemostatic disturbances in the early phase of trauma. Several studies have demonstrated an association between disseminated intravascular coagulation and mortality in patients with TBI \[[@b18-acc-2019-00640],[@b19-acc-2019-00640]\]. Another study found that the frequency of coagulopathy in blunt TBI was \~23% \[[@b20-acc-2019-00640]\]. In this study, 10.2% of TBI patients had hemostatic disturbances that required MT. However, unlike in non-TBI patients, the lactate level in TBI patients was not independently associated with MT. Anaerobic metabolism occurs when there is insufficient oxygen supply to tissues (due to bleeding in cases of trauma). Therefore, the lactate levels increase due to glycolysis after ischemic/hypoxic injury. However, TBI patients have a complex mechanism by which lactate production increases due to hyperglycolysis after severe brain injury and glycolysis after ischemic/hypoxic metabolism \[[@b21-acc-2019-00640]\]. Hyperglycolysis after severe brain injury is a phenomenon by which glutamate release increases (at the neuronal synapse) after severe brain injury. This glutamate release stimulates astrocyte glycolysis and blood glucose uptake \[[@b21-acc-2019-00640]\]. Sala et al. \[[@b22-acc-2019-00640]\] showed that the cerebral lactate level often increased in both ischemic and non-ischemic lesions after severe brain injury. However, elevated lactate levels were more prevalent in non-ischemic lesions \[[@b22-acc-2019-00640]\]. There were fewer ischemic lesions in the no-MT group than there were in the MT group. The lactate levels of the TBI patients were higher than were those of the non-TBI patients.

This study has several limitations. First, it was a retrospective study that was performed at a single center. Therefore, its findings are no immediately generalizable to the overall population. Further multi-center studies with larger sample sizes and prospective designs are needed to substantiate our findings. A second limitation is that 274 patients (28.2%) with severe trauma were excluded because their lactate levels were not obtained within 1 hour of admission. This exclusion criterion may have contributed to a selection bias. However, this exclusion criterion was meant to avoid measurements that were delayed until after resuscitation or those that were repeated (due to hemolysis). Finally, we did not analyze the effects of hemostasis treatments (such as interventions, operations, and transfusions) on mortality. Further research is needed to address these effects. In conclusion, the initial lactate level may be a possible prognostic factor for predicting MT in severe trauma. In non-TBI patients, the initial lactate level showed good prognostic performance with regard to MT. In TBI patients, the initial lactate level was not able to predict the need for MT.

HIGHLIGHTS
==========

■ The lactate level had fair prognostic performance in predicting massive transfusion (MT) in severe trauma patients.

■ The under the curve of lactate level for predicting MT in non-traumatic brain injury (non-TBI) patients was better than that in TBI patients.

■ The mechanism of lactate production in TBI and non-TBI may be different.
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###### 

Baseline characteristics according to massive transfusion

  Variable                             All patients (N=553)   No MT (n=491)       MT (n=62)           P-value
  ------------------------------------ ---------------------- ------------------- ------------------- ---------
  Age (yr)                             59 (45--72)            59 (46--73)         57 (37--72)         0.269
  Male sex                             411 (74.3)             364 (74.1)          47 (75.8)           0.776
  Medical history                                                                                     
   Hypertension                        163 (29.5)             150 (30.5)          13 (21.)            0.119
   Diabetes                            94 (17.0)              88 (17.9)           6 (9.7)             0.103
   Renal impairment                    5 (0.9)                4 (0.8)             1 (1.6)             0.532
  Mechanism of trauma                                                                                 0.008
   Blunt                               542 (98.0)             484 (98.6)          58 (93.5)           
   Penetrating                         11 (2.0)               7 (1.4)             4 (6.5)             
  Injury Severity Score (AIS)          22 (17--27)            22 (17--25)         26 (20--34)         \<0.001
   Head/neck                           2 (0--4)               2 (0--4)            0 (0--3)            0.124
   Face                                0 (0--0)               0 (0--0)            0 (0--0)            0.079
   Chest                               3 (0--3)               3 (0--3)            2 (0--3)            0.330
   Abdomen                             0 (0--3)               0 (0--3)            3 (0--4)            \<0.001
   Extremity/pelvic                    2 (0--3)               2 (0--2)            2 (0--3)            0.019
   External                            0 (0--1)               0 (0--1)            0 (0--1)            0.369
  Revised Trauma Score                 7.84 (6.13--7.84)      7.84 (6.38--7.84)   6.38 (4.34--7.11)   \<0.001
  Glasgow Coma Scale                   15 (9--15)             15 (9--15)          14 (5--15)          0.005
  SBP (mm Hg)                          110 (80--130)          110 (90--130)       75 (60--100)        \<0.001
  Respiratory rate (/min)              20 (20--22)            20 (20--22)         21 (20--24)         0.058
  Pulse rate (/min)                    88 (80--102)           88 (80--100)        99 (78--120)        0.031
  Laboratory test                                                                                     
   White blood cell count (×10^9^/L)   15.1 (10.4--19.1)      15.1 (10.5--19.0)   14.8 (10.1--20.5)   0.631
   Hemoglobin (g/dl)                   11.5 (9.8--13.3)       11.8 (10.0--13.5)   9.8 (7.9--11.2)     \<0.001
   Platelet count (×10^9^/L)           192 (150--233)         194 (154--237)      156 (124--216)      0.002
   AST (U/L)                           66 (37--152)           66 (37--143)        84 (37--287)        0.203
   ALT (U/L)                           39 (23--91)            39 (23--86)         42 (23--171)        0.559
   aPTT (sec)                          31.4 (27.4--37.6)      30.7 (27.0--35.8)   38.9 (31.6--66.8)   \<0.001
   PT-INR                              1.16 (1.07--1.33)      1.14 (1.06--1.28)   1.32 (1.17--1.80)   \<0.001
   Lactate (mmol/L)                    2.9 (1.7--4.9)         2.7 (1.6--4.3)      5.5 (3.8--9.0)      \<0.001
   Base deficit                        3.7 (0.8--7.4)         3.2 (0.5--6.4)      8.5 (4.8--14.0)     \<0.001
  PRC (unit)                           2 (0--5)               2 (0--4)            13 (11--16)         \<0.001
  FFP (unit)                           2 (0--4)               0 (0--3)            9 (6--14)           \<0.001
  PC (unit)                            0 (0--8)               0 (0--0)            10 (8--17)          \<0.001
  Emergency operation                  148 (26.8)             111 (22.6)          37 (59.7)           \<0.001
  Emergency intervention               84 (15.2)              73 (14.9)           11 (17.7)           0.776
  Hospital length of stay (day)        18 (10--34)            18 (10--32)         21 (2--52)          0.884
  ICU length of stay (day)             4 (2--10)              4 (2--9)            7 (2--16)           0.026
  In-hospital mortality                80 (14.8)              54 (11.0)           26 (41.9)           \<0.001
  30-Day mortality                     91 (16.5)              64 (13.0)           27 (43.5)           \<0.001

Values are presented as median (interquartile range) or number (%).

MT: massive transfusion; AIS: Abbreviated Injury Scale; SBP: systolic blood pressure; AST: aspartate transaminase; ALT: alanine aminotransferase; aPTT: activated partial thromboplastin time; PT-INR: international normalized ratio of prothrombin time; PRC: packed red blood cells; FFP: fresh frozen plasma; PC: platelet concentrates; ICU: intensive care unit.

###### 

Comparing baseline characteristics according to MT in TBI and non-TBI patients

  Variable                        TBI patient (n=244)   Non-TBI patient (n=309)                                                     
  ------------------------------- --------------------- ------------------------- --------- ------------------- ------------------- ---------
  Age (yr)                        64 (49--74)           52 (37--72)               0.122     57 (42--70)         57 (36--72)         0.994
  Male sex                        159 (72.6)            19 (76.0)                 0.717     205 (75.4)          28 (75.7)           0.967
  Medical history                                                                                                                   
   Hypertension                   73 (33.3)             5 (20.0)                  0.176     77 (28.3)           8 (21.6)            0.393
   Diabetes                       44 (20.1)             3 (12.0)                  0.331     44 (16.2)           3 (8.1)             0.200
   Renal impairment               2 (0.9)               0                         0.631     2 (0.7)             1 (2.7)             0.252
  Mechanism of trauma                                                             0.063                                             0.045
   Blunt                          218 (99.5)            24 (96.0)                           266 (97.8)          34 (91.9)           
   Penetrating                    1 (0.5)               1 (4.0)                             6 (2.2)             3 (8.1)             
  Injury Severity Score           25 (19--29)           27 (22--35)               0.014     20 (17--24)         25 (18--34)         \<0.001
  Revised Trauma Score            6.90 (5.03--7.84)     5.44 (2.63--6.38)         \<0.001   7.84 (7.11--7.84)   6.38 (5.97--7.48)   \<0.001
  Glasgow Coma Scale              10 (5--15)            6 (3--13)                 0.030     15 (15--15)         15 (12--15)         0.002
  SBP (mm Hg)                     120 (100--140)        70 (60--95)               \<0.001   100 (80--120)       80 (55--105)        \<0.001
  Respiratory rate (/min)         20 (20--22)           22 (20--24)               0.079     20 (20--22)         20 (20--24)         0.312
  Pulse rate (/min)               90 (80--100)          100 (79--115)             0.168     88 (80--100)        94 (76--121)        0.093
  Laboratory test                                                                                                                   
   WBC (×10^9^/L)                 14.9 (10.6--18.0)     14.3 (9.8--19.6)          0.804     15.3 (10.2--20.1)   15.8 (11.0--20.9)   0.499
   Hemoglobin (g/dl)              12.2 (10.3--13.7)     10.1 (7.9--11.3)          \<0.001   11.4 (9.8--13.2)    9.5 (7.7--11.2)     \<0.001
   Platelet count (×10^9^/L)      194 (154--233)        148 (111--223)            0.057     197 (155--238)      156 (129--210)      0.014
   AST (U/L)                      57 (34--107)          51 (33--277)              0.581     73 (40--208)        108 (42--329)       0.318
   ALT (U/L)                      35 (19--62)           35 (17--164)              0.936     44 (25--125)        47 (24--177)        0.635
   aPTT (sec)                     30.7 (26.9--37.2)     49.6 (30.4--76.9)         \<0.001   30.9 (27.0--35.6)   38.4 (31.6--44.9)   \<0.001
   PT-INR                         1.15 (1.06--1.30)     1.53 (1.10--1.83)         \<0.001   1.14 (1.06--1.28)   1.29 (1.18--1.53)   \<0.001
   Lactate (mmol/L)               3.3 (2.2--5.4)        5.3 (3.4--9.1)            0.002     2.3 (1.4--3.4)      5.6 (3.9--8.8)      \<0.001
   Base deficit                   3.1 (0.5--6.8)        7.4 (3.2--14.2)           \<0.001   3.3 (0.5--6.3)      9.4 (5.3--14.1)     \<0.001
  PRC (unit)                      2 (0--4)              13 (11--16)               \<0.001   2 (0--4)            13 (11--16)         \<0.001
  FFP (unit)                      0 (0--2)              8 (5--12)                 \<0.001   0 (0--4)            11 (7--14)          \<0.001
  PC (unit)                       0 (0--0)              10 (8--14)                \<0.001   0 (0--0)            10 (3--17)          \<0.001
  Emergency operation             46 (21.0)             13 (52.0)                 \<0.001   65 (23.9)           24 (64.9)           \<0.001
  Emergency intervention          14 (6.4)              5 (20.0)                  0.016     59 (21.7)           6 (16.2)            0.443
  Hospital length of stay (day)   16 (8--32)            19 (3--52)                0.567     19 (12--32)         25 (2--57)          0.725
  ICU length of stay (day)        7 (3--14)             8 (2--28)                 0.436     3 (1--6)            7 (2--13)           0.009
  In-hospital mortality           42 (19.2)             11 (44.0)                 0.004     12 (4.4)            15 (40.5)           \<0.001
  30-Day mortality                48 (21.9)             11 (44.0)                 0.015     16 (5.9)            16 (43.2)           \<0.001

Values are presented as median (interquartile range) or number (%).

MT: massive transfusion; TBI: traumatic brain injury; SBP: systolic blood pressure; WBC: white blood cell count; AST: aspartate transaminase; ALT: alanine aminotransferase; aPTT: activated partial thromboplastin time; PT-INR: international normalized ratio of prothrombin time; PRC: packed red blood cells; FFP: fresh frozen plasma; PC: platelet concentrates; ICU: intensive care unit.

###### 

AUC values for predicting massive transfusion in patients with severe trauma

  Variable                  AUC (95% CI)                                  
  ------------------------- ---------------------- ---------------------- ----------------------
  Injury Severity Score     0.651 (0.609--0.690)   0.649 (0.586--0.709)   0.666 (0.610--0.718)
  Revised Trauma Score      0.717 (0.677--0.754)   0.731 (0.670--0.785)   0.745 (0.693--0.793)
  Hemoglobin                0.726 (0.687--0.763)   0.717 (0.656--0.773)   0.728 (0.675--0.777)
  Systolic blood pressure   0.768 (0.730--0.802)   0.809 (0.754--0.857)   0.728 (0.675--0.777)
  Lactate level             0.779 (0.742--0.813)   0.690 (0.627--0.747)   0.842 (0.796--0.881)

AUC: area under the curve; CI: confidence interval; TBI: traumatic brain injury.

###### 

Prognostic performance of lactate levels for predicting massive transfusions in patients with severe trauma

  Variable                 Cutoff   Sensitivity (95% CI)   Specificity (95% CI)   PPV (95% CI)        NPV (95% CI)
  ------------------------ -------- ---------------------- ---------------------- ------------------- -------------------
  Lactate level (mmol/L)                                                                              
   Total patients          \>3.7    75.8 (63.3--85.8)      68.4 (64.1--72.5)      23.3 (20.0--26.9)   95.7 (93.5--97.2)
   TBI patient             \>5.0    60.0 (38.7--78.9)      74.9 (68.6--80.5)      21.4 (15.5--28.8)   94.3 (91.0--96.4)
   Non-TBI patient         \>3.6    81.1 (64.8--92.0)      77.2 (71.8--82.1)      32.6 (27.0--38.8)   96.8 (93.9--98.3)

CI: confidence interval; PPV: positive predictive value; NPV: negative predictive value; TBI: traumatic brain injury.

###### 

Logistic regression analysis for predicting massive transfusion

  Variable                          All patients           TBI patient   Non-TBI patient                                         
  --------------------------------- ---------------------- ------------- ---------------------- --------- ---------------------- ---------
  Mechanism                         0.178 (0.041--0.768)   0.021         0.195 (0.011--3.442)   0.265     0.139 (0.023--0.854)   0.033
  Injury Severity Score             1.026 (0.990--1.063)   0.155         1.010 (0.966--1.056)   0.657     1.110 (1.040--1.185)   0.002
  Revised Trauma Score              1.077 (0.875--1.325)   0.486         1.106 (0.790--1.547)   0.557     1.003 (0.674--1.492)   0.987
  Systolic blood pressure (mm Hg)   0.979 (0.968--0.990)   \<0.001       0.966 (0.953--0.980)   \<0.001   0.991 (0.973--1.009)   0.308
  Pulse rate (/min)                 0.998 (0.984--1.012)   0.760         \-                     \-        0.995 (0.975--1.016)   0.652
  Hemoglobin (g/dl)                 0.834 (0.740--0.940)   0.003         0.930 (0.808--1.069)   0.308     0.704 (0.582--0.851)   \<0.001
  Platelet count (×10^9^/L)         1.000 (0.995--1.004)   0.888         1.001 (0.993--1.009)   0.840     0.997 (0.989--1.004)   0.388
  aPTT (sec)                        1.005 (0.990--1.019)   0.524         1.005 (0.994--1.016)   0.401     0.987 (0.954--1.021)   0.437
  PT-INR                            0.713 (0.462--1.101)   0.127         0.773 (0.452--1.322)   0.347     0.226 (0.076--0.671)   0.007
  Lactate (mmol/L)                  1.179 (1.070--1.299)   \<0.001       1.002 (0.843--1.190)   0.985     1.469 (1.262--1.710)   \<0.001

TBI: traumatic brain injury; OR: odds ratio; CI: confidence interval; aPTT: activated partial thromboplastin time; PT-INR: international normalized ratio of prothrombin time.
